Jeffrey Meckler - CEO and Director, Director at Indaptus Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class
Common stock	203K	$238K	$1.18	Nov 25, 2024	Direct
Common Stock Warrants	42.6K	$50K	$1.18	Nov 25, 2024	Direct	Common Stock
Stock Option (Right to Buy)	75K			Oct 9, 2024	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.